Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The general aim is to evaluate the relative oral bioavailability of BI 44370 TA tablets
during and between migraine attacks as well as Safety, Tolerability and Pharmacokinetic